Handelsbanken Fonder’s Vera Therapeutics VERA Stock Holding History

Handelsbanken Fonder’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Buy	22,100 +2,300	+12%	+$85.7K	﹤0.01%	1166
2026 Q1	$797K	Hold	19,800	–	–	﹤0.01%	1143
2025 Q4	$1M	Sell	19,800 -1,700	-8%	-$60.4K	﹤0.01%	1024
2025 Q3	$625K	Buy	21,500 +4,900	+30%	+$113K	﹤0.01%	1193
2025 Q2	$391K	Buy	16,600 +2,800	+20%	+$63K	﹤0.01%	1348
2025 Q1	$331K	Hold	13,800	–	–	﹤0.01%	1376
2024 Q4	$584K	Hold	13,800	–	–	﹤0.01%	1230
2024 Q3	$610K	Buy	13,800 +2,200	+19%	+$83.5K	﹤0.01%	1165
2024 Q2	$420K	Buy	+11,600	New	+$460K	﹤0.01%	1228

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Handelsbanken Fonder's VERA Position: Q2 2026 in Review

Handelsbanken Fonder increased its Vera Therapeutics (VERA) stake by 12% in Q2 2026, buying an estimated $85.7K and bringing the position to 22,100 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Handelsbanken Fonder first reported a position in VERA in Q2 2024 and has held it in 9 quarters since. The position peaked at $1M in Q4 2025. 91 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Handelsbanken Fonder held 22,100 shares of Vera Therapeutics worth $948K as of Q2 2026.
Handelsbanken Fonder bought 2,300 Vera Therapeutics shares in Q2 2026, an estimated $85.7K.
Vera Therapeutics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1166 holding.
Handelsbanken Fonder first reported a position in Vera Therapeutics in Q2 2024 and has held it in 9 quarters since.
Handelsbanken Fonder's Vera Therapeutics position peaked at $1M in Q4 2025.
91 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.